CAVACURMIN®: Study Reveals Increased Metabolic Bioavailability of Tetrahydrocurcumin
A study recently published in the Journal of Functional Foods shows that ingestion of the curcumin-cyclodextrin complex CAVACURMIN® leads to an
Tag: gamma-cyclodextrin
OCULIS ANNOUNCES AN OVERSUBSCRIBED US$57 MILLION SERIES C FINANCING
New leading international life science investors join current institutional investors with proceeds to: Advance novel, late-stage Investigational ophthalmology drugs OCS-01
Regorafenib@mannose-γ-cyclodextrin channel-type nanoparticles for colorectal cancer therapy
The malignancy of colorectal cancer is connected with inflammation and tumor-associated macrophages (TAMs), but effective therapeutics for colorectal cancer are
Novel dexamethasone formulation shows efficacy and safety with once-daily use
Eric D. Donnenfeld, a consultant to Oculis reported for Ophthalmology Times on the results of a phase 2 trial: dexamethasone
Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease
Scientific report has published a paper on γ-cyclodextrin-enabled crocetin formulation which can deliver crocetin into the brain. [1] Crocetin (CRT)
Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease
Crocetin (CRT) has shown various neuroprotective effects such as antioxidant activities and the inhibition of amyloid β fibril formation, and
WACKER Confers Innovation Award for Development of CAVACURMIN®
Munich-based chemical group WACKER has conferred the Alexander Wacker Innovation Award on Rachela Mohr and Dr. Helmut Reuscher for developing
Gamma-cyclodextrin used in environmental friendly solvent production
cyclodextrinnews, gamma-cyclodextrin, fermentation, butanol production